86 related articles for article (PubMed ID: 38155375)
1. State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation.
Pathak PS; Chan G; Deming DA; Chee CE
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438466. PubMed ID: 38768405
[TBL] [Abstract][Full Text] [Related]
2. Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
Aoyama T; Yukawa N; Saito A
Anticancer Res; 2024 Apr; 44(4):1335-1351. PubMed ID: 38537954
[TBL] [Abstract][Full Text] [Related]
3. Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer.
Miyamoto Y; Zhang W; Lenz HJ
Indian J Surg Oncol; 2017 Dec; 8(4):580-590. PubMed ID: 29203992
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of metastatic colorectal cancer.
Cañellas-Socias A; Sancho E; Batlle E
Nat Rev Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38806657
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment for metastatic colorectal cancer.
Leowattana W; Leowattana P; Leowattana T
World J Gastroenterol; 2023 Mar; 29(10):1569-1588. PubMed ID: 36970592
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.
Lech G; Słotwiński R; Słodkowski M; Krasnodębski IW
World J Gastroenterol; 2016 Feb; 22(5):1745-55. PubMed ID: 26855534
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for colorectal cancer chemotherapy: Recent updates and future perspective.
Lee PY; Md Azhan FS; Low TY
Malays J Pathol; 2023 Dec; 45(3):317-331. PubMed ID: 38155375
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers in the treatment of metastatic colorectal cancer.
Wilson PM; Labonte MJ; Lenz HJ
Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
